Abaloparatide Real-World Patient Experience Study.

Area of Science:

• Bone Metabolism and Osteoporosis Research
• Patient-Reported Outcomes in Therapeutics

Background:

• Suboptimal adherence to osteoporosis treatments is a significant clinical challenge.
• Patient experience with therapy is a potential factor influencing treatment adherence.

Purpose of the Study:

• To describe the real-world patient experience with abaloparatide (ABL) injection in postmenopausal women at high risk for fracture.
• To identify factors associated with patient satisfaction and adherence to ABL therapy.

Main Methods:

• Multicenter, combined retrospective chart review and patient questionnaire study in the US.
• Inclusion of 193 postmenopausal women at high risk for fracture.
• Assessment of patient satisfaction, ease of preparation/storage, daily activity integration, and adherence.

Main Results:

• 86% of patients were satisfied with the ABL regimen, citing ease of preparation (82%) and storage (87%).
• 85% reported satisfaction with ABL's integration into daily activities, and 83% reported medium to high adherence.
• Ease of preparation and fracture history were significantly associated with overall satisfaction.

Conclusions:

• The majority of patients are satisfied with abaloparatide, finding it convenient and easy to prepare and store.
• High self-reported adherence may be linked to positive patient experiences, including ease of use and healthcare provider support.
• Addressing patient-reported bothersome attributes like injection discomfort and cost could further enhance treatment experience.